-
FEATURED
Plenary III highlights emerging insights into knee OA, PMR, APS, gout, JIA, and RA
In the third plenary session at ACR Convergence, Stephen Messier, PhD, discussed a pragmatic randomized trial that demonstrated how intensive diet and exercise can reduce knee pain in knee osteoarthritis in community-based settings as effectively as in academic settings. READ MORE
#ACR22 SESSION COVERAGE
-
ARP Keynote speaker reignites passion in practice by redefining success
People who work in healthcare are taught to be stoic and objective. At the same time, 60 percent of these professionals report experiencing mental health repercussions from their work. Kathleen Flarity, DNP, PhD, CEN, CFRN, FAEN, FAAN, addressed confronting these challenges. READ MORE
-
Late-Breaking Abstracts session features innovative research from six timely studies
New discoveries pave the way for possible new approaches to treating patients with autoimmune and autoinflammatory diseases. Research by Giovanni Adami, MD, could support anti-osteoporotic treatments for patients taking low-dose glucocorticoids. READ MORE
-
Investigators unveil draft of new classification criteria for antiphospholipid syndrome
New classification criteria for APS presented at ACR Convergence 2022 are under review by ACR/EULAR and pending final approval. The highly specific, evidence-based criteria will help identify patients with a high likelihood of APS for clinical research, said Medha Barbhaiya, MD, MPH. READ MORE
-
ACR drafts inaugural guideline for integrated care for RA
The first ACR guideline for integrated treatment related to rheumatoid arthritis provides direction on physical, psychosocial, mind-body, and nutritional interventions through a shared decision-making approach. Bryant England, MD, PhD, RhMSUS, and other speakers underscored the need for an interprofessional team to effectively treat patients. READ MORE
-
First-ever CPPD classification criteria presented
The proposed criteria, in development since 2019, will help clinicians more accurately diagnose and treat calcium pyrophosphate deposition disease and encourage renewed research into this disease, said Sara K. Tedeschi, MD, MPH, who was one of the co-leaders of the criteria project. READ MORE
-
New ACR vaccination guideline in press
With the recognition that rheumatic and musculoskeletal diseases (RMDs) and immunosuppression can affect the immunogenicity and safety of vaccines, the ACR has issued its own guideline for vaccination in patients with RMDs. Project leader Anne Bass, MD, and other panelists outlined the new recommendations at ACR Convergence. READ MORE
POSTER SPOTLIGHT
-
Kristin Wipfler, PhD: Impact on Access to Methotrexate in the Post-Roe Era
Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk. READ MORE
-
Matthew C. Baker, MD, MS: Sarcoidosis Incidence after mTOR Inhibitor Treatment
Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk. READ MORE
-
Robert M. Hamilton, MD, MHSc, FRCP(C): Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block
Robert M. Hamilton, MD, MHSc, FRCP(C), will discuss the poster “Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block” in a Monday afternoon Ignite Talk. READ MORE
-
Sabine Sparre Dieperink, MD: The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry
Sabine Sparre Dieperink, MD, will discuss the poster “The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Regis” in a Monday afternoon Ignite Talk. READ MORE